Granite Investment Partners’s Kindred Biosciences, Inc. KIN Stock Holding History

Granite Investment Partners’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-25,297	Closed	-$211K	–	378
2019 Q2	$211K	Sell	25,297 -22,208	-47%	-$192K	0.01%	327
2019 Q1	$436K	Buy	47,505 +32,649	+220%	+$332K	0.02%	309
2018 Q4	$163K	Buy	+14,856	New	+$187K	0.01%	326
2018 Q1	–	Sell	-92,274	Closed	-$872K	–	320
2017 Q4	$872K	Hold	92,274	–	–	0.06%	235
2017 Q3	$724K	Sell	92,274 -48,102	-34%	-$361K	0.05%	245
2017 Q2	$1.21M	Sell	140,376 -6,766	-5%	-$48.5K	0.08%	212
2017 Q1	$1.04M	Sell	147,142 -5,817	-4%	-$36.4K	0.07%	228
2016 Q4	$650K	Buy	+152,959	New	+$740K	0.05%	262

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Granite Investment Partners's KIN Position: Q3 2019 in Review

Granite Investment Partners sold out of Kindred Biosciences, Inc. (KIN) in Q3 2019, closing a stake of 25,297 shares — an estimated $211K sold.

Granite Investment Partners first reported a position in KIN in Q4 2016 and held it in 8 quarters. The position peaked at $1.21M in Q2 2017. 72 funds tracked by Wall St. Rank hold KIN as of Q3 2019.

Granite Investment Partners reported no remaining Kindred Biosciences, Inc. position as of Q3 2019 after selling out during the quarter.
Granite Investment Partners sold 25,297 Kindred Biosciences, Inc. shares in Q3 2019, an estimated $211K.
Granite Investment Partners first reported a position in Kindred Biosciences, Inc. in Q4 2016 and held it in 8 quarters.
Granite Investment Partners's Kindred Biosciences, Inc. position peaked at $1.21M in Q2 2017.
72 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2019.

Based on Granite Investment Partners's 13F filing for Q3 2019, filed 12 Nov 2019.